Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden

American Journal of Transplantation

Volumn 11, Issue 1, 2011, Pages 146-151

  Simard, J F ^a   Baecklund, E ^b   Kinch, A ^b   Brattstrom C ^c   Ingvar, A ^a   Molin, D ^b   Adami, J ^a   Fernberg, P ^a   Wilczek, H ^c   Ekbom, A ^a   Smedby, K E ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer; malignancy; pediatric solid organ transplantation; pediatric transplant

Indexed keywords

ADOLESCENT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; KIDNEY CARCINOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; NEWBORN; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PEDIATRIC SURGERY; PRECANCER; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SKIN CANCER; SWEDEN; VAGINA CANCER; VULVA CANCER;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASMS; ORGAN TRANSPLANTATION; RISK; SKIN NEOPLASMS; SWEDEN;

EID: 78650880616     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03367.x     Document Type: Article

References (25)

1. Opelz G, Dohler B,. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222-230.
2. Feng S,. Long-term management of immunosuppression after pediatric liver transplantation: Is minimization or withdrawal desirable or possible or both? Curr Opin Organ Transplant 2008; 13: 506-512.
3. Adami J, Gabel H, Lindelof B, et al,. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227.
4. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM,. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370: 59-67.
5. Vajdic CM, McDonald SP, McCredie MR, et al,. Cancer incidence before and after kidney transplantation. Jama 2006; 296: 2823-2831.
6. Vajdic CM, van Leeuwen MT, Webster AC, et al,. Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev 2009; 18: 2297-2303.
7. Debray D, Baudouin V, Lacaille F, et al,. De novo malignancy after solid organ transplantation in children. Transplant Proc 2009; 41: 674-675.
8. Guariso G, Visona Dalla Pozza L, Manea S, Salmaso L, Lodde V, Facchin P,. Italian experience of pediatric liver transplantation. Pediatr Transplant 2007; 11: 755-763.
9. Haberal M, Sevmis S, Karakayali H, et al,. Pediatric liver transplant: Results of a single center. Exp Clin Transplant 2008; 6: 7-13.
10. Socialstyrelsen. In-patient diseases in Sweden 1987-2003. In: National Bureau of Health and Welfare, ed. Stockholm, 2005.
11. Socialstyrelsen. In English: The National Patient Register. 2010. Available at:. Accessed October 21, 2010.
12. Nilsson AC, Spetz CL, Carsjo K, Nightingale R, Smedby B,. Reliability of the hospital registry. The diagnostic data are better than their reputation. Lakartidningen 1994; 91: 598, 603- 595.
13. Troeng T, Malmstedt J, Bjorck M,. External validation of the Swedvasc registry: A first-time individual cross-matching with the unique personal identity number. Eur J Vasc Endovasc Surg 2008; 36: 705-712.
14. Bonsib SM,. Renal cystic diseases and renal neoplasms: A mini-review. Clin J Am Soc Nephrol 2009; 4: 1998-2007.
15. Malinge S, Ragu C, Della-Valle V, et al,. Activating mutations in human acute megakaryoblastic leukemia. Blood 2008; 112: 4220-4226.
16. Johannesson M, Askling J, Montgomery SM, Ekbom A, Bahmanyar S,. Cancer risk among patients with cystic fibrosis and their first-degree relatives. Int J Cancer 2009; 125: 2953-2956.
17. Mattsson B, Wallgren A,. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305-313.
18. Barlow L, Westergren K, Holmberg L, Talback M,. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009; 48: 27-33.
19. Koukourgianni F, Harambat J, Ranchin B, et al,. Malignancy incidence after renal transplantation in children: A 20-year single centre experience. Nephrol Dial Transplant 2009; 25: 611-616.
20. Matin RN, Mesher D, Proby CM, et al,. Melanoma in organ transplant recipients: Clinicopathological features and outcome in 100 cases. Am J Transplant 2008; 8: 1891-1900.
21. Geusau A, Dunkler D, Messeritsch E, et al,. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Int J Dermatol 2008; 47: 918-925.
22. Aberg F, Pukkala E, Hockerstedt K, Sankila R, Isoniemi H,. Risk of malignant neoplasms after liver transplantation: A population-based study. Liver Transpl 2008; 14: 1428-1436.
23. Ingvar A, Smedby KE, Lindelof B, et al,. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant 2010; 25: 2764-2771.
24. van Leeuwen MT, Grulich AE, McDonald SP, et al,. Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev 2009; 18: 561-569.
25. van Leeuwen MT, Grulich AE, Webster AC, et al,. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood 2009; 114: 630-637.